Electromed, Inc. (NYSEMKT:ELMD) major shareholder Red Oak Partners, Llc sold 34,858 shares of Electromed stock in a transaction on Tuesday, October 3rd. The shares were sold at an average price of $7.50, for a total transaction of $261,435.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Red Oak Partners, Llc also recently made the following trade(s):

  • On Monday, October 2nd, Red Oak Partners, Llc sold 4,600 shares of Electromed stock. The shares were sold at an average price of $7.51, for a total transaction of $34,546.00.
  • On Friday, September 22nd, Red Oak Partners, Llc sold 7,455 shares of Electromed stock. The shares were sold at an average price of $7.40, for a total transaction of $55,167.00.
  • On Wednesday, September 20th, Red Oak Partners, Llc sold 184,336 shares of Electromed stock. The shares were sold at an average price of $7.53, for a total transaction of $1,388,050.08.
  • On Thursday, September 21st, Red Oak Partners, Llc sold 262,475 shares of Electromed stock. The shares were sold at an average price of $7.52, for a total transaction of $1,973,812.00.

Shares of Electromed, Inc. (NYSEMKT ELMD) traded down 1.75% during trading on Wednesday, hitting $7.28. 18,472 shares of the company’s stock were exchanged. Electromed, Inc. has a 1-year low of $3.38 and a 1-year high of $7.96. The firm has a market capitalization of $60.13 million, a PE ratio of 28.00 and a beta of 0.89. The stock’s 50 day moving average is $6.97 and its 200 day moving average is $5.66.

Electromed (NYSEMKT:ELMD) last announced its quarterly earnings data on Tuesday, September 5th. The medical equipment provider reported $0.11 EPS for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.05. Electromed had a net margin of 13.01% and a return on equity of 20.48%. The firm had revenue of $7.27 million for the quarter. On average, equities research analysts forecast that Electromed, Inc. will post $0.19 earnings per share for the current year.

WARNING: “Electromed, Inc. (ELMD) Major Shareholder Red Oak Partners, Llc Sells 34,858 Shares” was reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/10/04/electromed-inc-elmd-major-shareholder-red-oak-partners-llc-sells-34858-shares.html.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Spark Investment Management LLC grew its position in Electromed by 47.4% in the first quarter. Spark Investment Management LLC now owns 61,316 shares of the medical equipment provider’s stock worth $302,000 after acquiring an additional 19,716 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Electromed by 12.2% in the first quarter. Dimensional Fund Advisors LP now owns 143,127 shares of the medical equipment provider’s stock worth $706,000 after acquiring an additional 15,559 shares in the last quarter. Essex Investment Management Co. LLC bought a new stake in Electromed in the second quarter worth approximately $166,000. Algert Global LLC grew its position in Electromed by 7.2% in the second quarter. Algert Global LLC now owns 58,460 shares of the medical equipment provider’s stock worth $323,000 after acquiring an additional 3,925 shares in the last quarter. Finally, Tocqueville Asset Management L.P. grew its position in Electromed by 143.7% in the second quarter. Tocqueville Asset Management L.P. now owns 301,103 shares of the medical equipment provider’s stock worth $1,665,000 after acquiring an additional 177,565 shares in the last quarter.

About Electromed

Electromed, Inc develops, manufactures and markets airway clearance products, which apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The Company’s products include the SmartVest Airway Clearance System (SmartVest System), the SmartVest SQL System and others.

Insider Buying and Selling by Quarter for Electromed (NYSEMKT:ELMD)

Receive News & Ratings for Electromed Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed Inc. and related companies with MarketBeat.com's FREE daily email newsletter.